Two global forces are at odds today - the push for “greener” processes and the push for lower drug prices.

Stereokem's business focus is to develop and capture IP on innovative chemistries (non-infringing) and cost-effective manufacturing processes for emerging block buster Generic Active Pharmaceutical Ingredients.

The primary objective is to support our customers with para-IV filings in the regulated markets. With products provided years before innovator/brand patents expire to enable early formulation studies and regulatory submissions (ANDA's) in countries having Roche Bolar or equivalent amendments, our processes are non-infringing, and products are supplied at price-competitive levels.